BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 11248749)

  • 21. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women.
    Söderberg S; Olsson T; Eliasson M; Johnson O; Ahrén B
    J Intern Med; 1999 May; 245(5):533-43. PubMed ID: 10363755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
    Undén AL; Elofsson S; Brismar K
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).
    López-Bermejo A; Khosravi J; Fernández-Real JM; Hwa V; Pratt KL; Casamitjana R; Garcia-Gil MM; Rosenfeld RG; Ricart W
    Diabetes; 2006 Aug; 55(8):2333-9. PubMed ID: 16873698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1-3 in premenopausal women: physical activity and anthropometry (Netherlands).
    Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Rinaldi S; Riboli E; Grobbee DE; Peeters PH
    Cancer Causes Control; 2001 Dec; 12(10):951-8. PubMed ID: 11808715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density.
    Diorio C; Pollak M; Byrne C; Mâsse B; Hébert-Croteau N; Yaffe M; Coté G; Bérubé S; Morin C; Brisson J
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1065-73. PubMed ID: 15894654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60.
    Kim JG; Shin CS; Choi YM; Moon SY; Kim SY; Lee JY
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):301-7. PubMed ID: 10469009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of circulating IGF-I and IGFBP-3 levels by hormonal regulators of energy homeostasis in obese children.
    Woelfle JF; Harz K; Roth C
    Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):17-23. PubMed ID: 17286229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic, anthropometric, and nutritional factors as predictors of circulating insulin-like growth factor binding protein-1 levels in middle-aged and elderly men.
    Wolk K; Larsson SC; Vessby B; Wolk A; Brismar K
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1879-84. PubMed ID: 15070959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P; Brismar K; Rosenfeld RG; Hall K
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone-binding protein is directly and IGFBP-3 is inversely associated with risk of female breast cancer.
    Pazaitou-Panayiotou K; Kelesidis T; Kelesidis I; Kaprara A; Blakeman J; Vainas I; Mpousoulegas A; Williams CJ; Mantzoros C
    Eur J Endocrinol; 2007 Feb; 156(2):187-94. PubMed ID: 17287408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses' Health Studies.
    Rice MS; Tworoger SS; Rosner BA; Pollak MN; Hankinson SE; Tamimi RM
    Breast Cancer Res Treat; 2012 Dec; 136(3):805-12. PubMed ID: 23085768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum concentrations of insulin, insulin-like growth factor(IGF)-I, IGF binding protein (IGFBP)-1 and -3 and growth hormone binding protein in obese children: fasting IGFBP-1 is suppressed in normoinsulinaemic obese children.
    Saitoh H; Kamoda T; Nakahara S; Hirano T; Nakamura N
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):487-92. PubMed ID: 9640416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor 21 (FGF-21) in obese children: no relationship to growth, IGF-1, and IGFBP-3.
    Reinehr T; Roth CL; Woelfle J
    Horm Mol Biol Clin Investig; 2016 Feb; 30(2):. PubMed ID: 26887040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
    Serin IS; Tanriverdi F; Yilmaz MO; Ozcelik B; Unluhizarci K
    Gynecol Endocrinol; 2008 Mar; 24(3):117-21. PubMed ID: 18335323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal association between IGFBP-1 levels and parameters of the metabolic syndrome in obese children before and after weight loss.
    Reinehr T; Kleber M; Toschke AM; Woelfle J; Roth CL
    Int J Pediatr Obes; 2011 Aug; 6(3-4):236-43. PubMed ID: 21198359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
    Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
    Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
    Münzer T; Rosen CJ; Harman SM; Pabst KM; St Clair C; Sorkin JD; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated leptin concentrations in growth hormone-deficient hypopituitary adults.
    al-Shoumer KA; Anyaoku V; Richmond W; Johnston DG
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):153-9. PubMed ID: 9302387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
    Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels.
    Cano A; Castelo-Branco C; Tarín JJ
    Fertil Steril; 1999 Feb; 71(2):261-7. PubMed ID: 9988395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.